|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| C07D 487/04 | |||
| C07D 487/16 | |||
| C07D 519/00 | |||
| A61K 31/5517 | |||
| A61P 35/00 |
| (11) | Number of the document | 2968596 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14761432.5 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/025564 |
| Date | 2014-03-13 |
| (87) | Number | WO 2014/159981 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361778771 P | 2013-03-13 | US |
| (72) |
HOWARD, Philip, Wilson, GB
FLYGARE, John, A., US
PILLOW, Thomas, US
WEI, Binqing, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
MEDIMMUNE LIMITED, Milstein Building Granta Park, Cambridge CB21 6GH, GB |
| (54) | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |
| PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |